Oral Prednisolone, Etoposide, 6- Mercaptopurine (PREM) metronomic chemotherapy in treatment naïve and partially treated acute myeloid leukemia in a resource constrained setting
Background: Standard 3 + 7 induction (anthracycline + cytarabine) and consolidation high-dose cytarabine are toxic, expensive, and resource intensive. Objectives: The objective was to evaluate response rates and survival with PRednisolone, Etoposide and 6-Mercaptopurine (PREM) metronomic chemotherap...
Main Authors: | Avinash Pandey, Prashant Deshpande, Anjana Singh, Shivkant Singh, Krishna Murari, Raj Aryan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Cancer Research, Statistics, and Treatment |
Subjects: | |
Online Access: | http://www.crstonline.com/article.asp?issn=2590-3233;year=2020;volume=3;issue=2;spage=172;epage=182;aulast=Pandey |
Similar Items
-
Oral etoposide and cyclophosphamide: A low-cost palliative metronomic chemotherapy in advanced pediatric cancers
by: Kiran Kumar, et al.
Published: (2020-01-01) -
Metronomic combination chemotherapy using everolimus and etoposide for the treatment of non‐Hodgkin lymphoma
by: Ke Wu, et al.
Published: (2019-08-01) -
Navigating the financial impasse in acute myeloid leukemia: Prednisolone, etoposide, and 6-mercaptopurine metronomic chemotherapy
by: Vishal Jayakar
Published: (2020-01-01) -
Outcomes of advanced epithelial ovarian cancer with integration of metronomic chemotherapy: An Indian rural cancer centre experience
by: Avinash Pandey, et al.
Published: (2016-01-01) -
Metronomic chemotherapy regimens in oncology
by: M. Yu. Fedyanin, et al.
Published: (2016-04-01)